Press Release June 11, 2018

Scholar Rock Closes $86.3 Million Initial Public Offering

The Life Sciences team advised Scholar Rock (“SRRK”) on the closing of its initial public offering of 6,164,000 shares of common stock at the public offering price of $14.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 804,000 additional shares. The gross proceeds from the offering were approximately $86.3 million, before deducting underwriting discounts and commissions and estimated offering expenses.

Scholar Rock is a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.

The Goodwin team was led by partners Laurie Burlingame and Kingsley Taft and included associates James Xu, Sam Davis, Michael Cohen and Stephen Fox.

For more information on the offering, please read the press release.